Tous nos rayons

Déjà client ? Identifiez-vous

Mot de passe oublié ?

Nouveau client ?

CRÉER VOTRE COMPTE
Summary of john abramson's sickening
Ajouter à une liste

Librairie Eyrolles - Paris 5e
Indisponible

Summary of john abramson's sickening

Summary of john abramson's sickening

  Everest Media

Parution le 19/03/2022

Résumé

Please note: This is a companion version & not the original book. Sample Book Insights: #1 The author was sent a heartbreaking note from a woman who had seen her on television discussing safety issues associated with Vioxx and Celebrex, two widely used pain relievers. She asked if she could review her daughter's medical records.#2 As the Palmer family struggled with their loss, one of the world's largest drug companies was dealing with a crisis of its own. On September 30, 2004, Merck pulled its blockbuster Vioxx off the market.#3 The two articles that defended Vioxx were published in the world's most prestigious medical journal, the NEJM. But when I read the fine print, I was shocked to discover that both authors had financial ties to Merck.#4 I realized that the information in the NEJM could not be trusted. I searched for the data behind an article I'd read in the Washington Post, which reported that a JAMA article claiming to show that Celebrex caused fewer serious GI complications than older over-the-counter anti-inflammatory drugs was also based on a misrepresentation.

Caractéristiques techniques

  NUMERIQUE
Éditeur(s) Everest Media LLC
Auteur(s)   Everest Media
Parution 19/03/2022
Contenu ePub
EAN13 9781669354659

Avantages Eyrolles.com

Livraison à partir de 0,01 en France métropolitaine
Paiement en ligne SÉCURISÉ
Livraison dans le monde
Retour sous 15 jours
+ d'un million et demi de livres disponibles
satisfait ou remboursé
Satisfait ou remboursé
Paiement sécurisé
modes de paiement
Paiement à l'expédition
partout dans le monde
Livraison partout dans le monde
Service clients sav.client@eyrolles.com
librairie française
Librairie française depuis 1925
Recevez nos newsletters
Vous serez régulièrement informé(e) de toutes nos actualités.
Inscription